FDA Warns 30 Telehealth Firms Over Misleading Compounded GLP-1 Ads

This is the second group of warning letters the FDA has sent to telehealth firms since September 2025.

by is licensed under

Follow us

Read our latest news on any of these social networks!

Get latest news delivered daily!

We will send you breaking news right to your inbox

[ADD FORM IN PSYCODE "follow-us-card"]

Have a tip? Let us know!